Four takeaways from the latest round of federal CBD warning letters

The young CBD industry is growing accustomed to federal health authorities warning companies not to make medical claims about the cannabinoid. But a round of warning letters this week from the U.S. Federal Trade Commission (FTC) – the consumer-protection agency that safeguards against unfair and deceptive advertising – served as a reminder that as CBD goes […]

Four takeaways from the latest round of federal CBD warning letters is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

* This article was originally published here

Please follow and like us: